The Effect of Emotional Freedom Techniques (EFT) in Smokers Failing a Smoking Cessation Program

ConditionSmoking
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age12-99
SponsorSoul Medicine Institute

About this trial

The National Health Service (NHS) stop smoking service at the Central Lancashire NHS Trust serves a diverse population of smokers, with a very good quit rate and high standards. However, clinical experience predicts that some clients are unlikely to succeed through the NHS smoking cessation program. This special population has difficulty quitting for a variety of reasons. Some relapse over the course of the following two years and return repeatedly to the service. Others, for instance those with health problems, may be highly motivated to quit, but unable to resist their cravings. The purpose of this study is to determine if EFT makes a difference in quit rates with the most challenging population of clients.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

High anxiety related to the quit attempt

Cravings which sabotage the quit attempt

Low confidence at their ability to quit and remain quit

Disqualifiers

None, all NHS clients are eligible

Trial design

Design model

Parallel

Treatments tested in this trial

  • EFT (Emotional Freedom Techniques)

    Behavioral

    EFT is a brief but efficacious stress-reduction intervention. It combines exposure, cognitive structuring, and somatic stimulation.

  • CBT (Cognitive Behavioral Therapy)

    Behavioral

    CBT is a behavioral intervention that seeks to challenge and change negative client cognitions about events and life circumstances.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: CBTActive comparator 1 intervention
Group B: EFTExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Quit rate

Time frame
treatment period

Secondary outcomes

1

Psychological symptoms and physiological symptoms

Symptoms and smoking 3, 6 and 12 months post-intervention

Time frame
Three, 6, and 12 months after intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.